Transgenic mouse models have also been established to model the role of the Flt3 (Fms-related tyrosine kinase 3) internal tandem repeats (FLT3-ITD) mutation found in > 20% of human AML [90]. This evidence concerns the gene FLT3 and acute myeloid leukemia.